CGK 733

製品コードS7136 バッチS713601

印刷

化学情報

Chemical Structure Synonyms N/A Storage
(From the date of receipt)		 3 years -20°C powder
1 years -80°C in solvent
化学式

C23H18Cl3FN4O3S
分子量 555.84 CAS No. 905973-89-9
Solubility (25°C)* 体外 DMSO 100 mg/mL (179.9 mM)
Water Insoluble
Ethanol Insoluble
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液（一定の濃度）を調合する

生物活性

製品説明 CGK 733は、ATM/ATRの強力かつ選択的な阻害剤であり、IC50は約200 nMです。
in vitro CGK733 is able to confer robust growth to senescent cells that have ceased proliferation. Senescence-associated β-galactosidase (SA–β-gal) activity disappears in CGK733-treated cells. CGK733 shows greater potency in inhibiting ATM/ATR than LY294002 (IC50 , ~5 μM for ATM and ATR), a pan-inhibitor of PI3K and PIKKs. CGK733 (30 μM) treated for 24h causes ~60% cell death in senescent MCF-7 cells. CGK733 (20 μM) induces the loss of cyclin D1 via the ubiquitin- dependent proteasomal degradation pathway in MCF-7 and T47D breast cancer cell lines. CGK733 at concentrations ranging from 0.6- 40 μM, inhibits proliferation of MCF-7 and T47D estrogen receptor (ER) positive breast cancer cells, MDA-MB436 ER negative breast cancer cells, LnCap pros-tate cancer cells and HCT116 colon cancer cells. Furthermore, CGK733 also suppresses proliferation of non- transformed mouse BALB/c 3T3 embryonic fibroblast cells. The CGK733-mediated inhibition of proliferation is dose dependent and significant at doses as low as 2.5 μM.

プロトコル(参考用のみ)

細胞アッセイ 細胞株 Human breast cancers cell line MCF-7
濃度 ~20 μM
反応時間 2 days
実験の流れ Cells are seeded in 96-well plates at a predetermined, optimal cell density to ensure exponential growth for duration of the assay. After a 24 h preincubation, growth medium is replaced with experimental medium containing the appropriate drug concentrations or 0.1% (v/v) vehicle control. After a 48 h incubation, cell proliferation is estimated using the sulforhodamine B colorimetric assay.

参考

  • https://pubmed.ncbi.nlm.nih.gov/16767085/
  • https://pubmed.ncbi.nlm.nih.gov/18347191/
  • https://pubmed.ncbi.nlm.nih.gov/19903334/

カスタマーフィードバック

Data from [Data independently produced by , , Molecules and Cells， 2016， 39(12): 869-876.]

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

p53-driven replication stress in nucleoli of malignant epithelial ovarian cancer [ Exp Cell Res, 2022, S0014-4827(22)00218-X] PubMed: 35644414
Selenomethionine protects hematopoietic stem/progenitor cells against cobalt nanoparticles by stimulating antioxidant actions and DNA repair functions [ Aging (Albany NY), 2021, 13(8):11705-11726] PubMed: 33875618
Involvement of Host ATR-CHK1 Pathway in Hepatitis B Virus Covalently Closed Circular DNA Formation. [ mBio, 2020, 11(1)] PubMed: 32071277
Cantharidin Overcomes Imatinib Resistance by Depleting BCR-ABL in Chronic Myeloid Leukemia. [Sun X, et al. Mol Cells, 2016, 39(12):869-876] PubMed: 27989101
URI1 amplification in uterine carcinosarcoma associates with chemo-resistance and poor prognosis [ Am J Cancer Res, 2015, 5(7):2320-9] PubMed: 26328264

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。